Status:

RECRUITING

Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France

Lead Sponsor:

Centre Hospitalier Universitaire de Nīmes

Conditions:

Renal Insufficiency, Chronic

Eligibility:

All Genders

Brief Summary

The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory ...

Eligibility Criteria

Inclusion Criteria:

  • chronic kidney disease (stage >= 4)

Exclusion Criteria:

-

Key Trial Info

Start Date :

January 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

3375 Patients enrolled

Trial Details

Trial ID

NCT02938611

Start Date

January 1 2019

End Date

December 1 2025

Last Update

March 10 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

AIDER - Unité de Dialyse d'Alès

Alès, France, 30100

2

AIDER - Unité de Dialyse de Nîmes, CHU Carémeau

Nîmes, France, 30029

3

CHU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, France, 30029

4

Gardialyse

Nîmes, France, 30900

Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France | DecenTrialz